Skip to main content
DNA Labs India

HLA Hypersensitivity to Carbamazepine & Phenytoin (B*15:02) Test

DNA Labs India | ISO 9001:2015 Certified

HLA Hypersensitivity to Carbamazepine & Phenytoin (B*15:02) Test

Short Name: HLA B*15:02 Test

Also known as: HLA-B*15:02 Genotyping, Carbamazepine Hypersensitivity Test, Phenytoin Hypersensitivity Test, SJS/TEN Risk Test

HLA Hypersensitivity to Carbamazepine & Phenytoin (B*15:02) Test test available at DNA Labs India for ₹8,000. Uses PCR, Sequencing on Whole blood or Buccal swab samples. Results in 10-12 days. Free home collection in 300+ cities across India.

Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify individuals carrying the HLA-B*15:02 allele who are at increased risk of developing severe hypersensitivity reactions, such as SJS/TEN, when taking carbamazepine or phenytoin. This enables proactive medication selection to avoid life-threatening adverse effects.

Test Code
814
CPT Code
81381
ICD Code
L27.1
Price
₹8,000
Sample Type
Whole blood or Buccal swab
Result Time
10-12 days
Fasting Required
No
Method
PCR, Sequencing
Step 1

Sample Collection

No special preparation required. Inform the healthcare provider about any medications or recent transfusions.

Method: Blood draw or Buccal swab collection

Step 2

Laboratory Analysis

A blood sample will be drawn from a vein in the arm using a needle, or a buccal swab will be collected by rubbing the inside of the cheek. The procedure is quick and minimally invasive.

Step 3

Report Delivery

Apply pressure to the blood collection site to prevent bruising. Resume normal activities immediately. For buccal swabs, avoid eating or drinking for 30 minutes prior.

Timeline: 10-12 days

Patient Instructions

1
Before the Test:No special preparation required. Ensure proper sample collection instructions are followed.
2
During the Test:Sample collection takes 5-10 minutes. Blood draw or buccal swab is performed by a trained phlebotomist.
3
After the Test:You can resume normal activities immediately. Results will be available in 10-12 days via online portal, email, or WhatsApp.

About This Test

Who Should Get This Test

The purpose of this test is to identify individuals carrying the HLA-B*15:02 allele who are at increased risk of developing severe hypersensitivity reactions, such as SJS/TEN, when taking carbamazepine or phenytoin. This enables proactive medication selection to avoid life-threatening adverse effects.

How to Prepare

  • For blood collection: Clean the site with antiseptic, draw 4-6 mL blood into specified tube
  • For buccal swab: Rub the swab firmly against the inner cheek for 30 seconds
  • Label samples correctly with patient details
  • Ship refrigerated; do not freeze

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test is critical for patients initiating or currently on carbamazepine or phenytoin to prevent potentially fatal skin reactions like SJS/TEN. Early identification of HLA-B*15:02 carriers allows for safer medication alternatives."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeWhole blood or Buccal swab
Sample Volume4 mL (3 mL min.) whole blood in EDTA tube, 6 mL (3 mL min.) whole blood in ACD tube, or Buccal swab
ContainerLavender Top (EDTA) tube, Yellow Top (ACD) tube, or Sterile container for buccal swab
Collection MethodBlood draw or Buccal swab collection

Sample Stability

Sample Rejection Criteria:
  • Incorrect sample type or container
  • Samples hemolyzed, clotted, or insufficient volume
  • Improper labeling or storage conditions
  • Leaking or damaged containers

Understanding Your Results

Results indicate the presence or absence of the HLA-B*15:02 allele. Clinical correlation is essential for appropriate management.
📊

HLA-B*15:02 Detected

Positive result indicates an increased risk of developing SJS/TEN when exposed to carbamazepine or phenytoin. Avoid use of these drugs and consult a healthcare provider for alternative treatments.

Action: Discuss medication alternatives with your doctor.

📊

HLA-B*15:02 Not Detected

Negative result suggests a lower risk, but not zero risk, of hypersensitivity reactions. Standard precautions should still be taken.

Action: Monitor for any adverse symptoms during drug therapy.

⚠️ When to Consult a Doctor:

If you test positive for HLA-B*15:02, consult your doctor immediately to review your medication regimen. Also, seek medical attention if you experience symptoms like skin rash, fever, or blistering while taking carbamazepine or phenytoin.

Limitations

  • This test only screens for HLA-B*15:02 and not other HLA alleles associated with drug hypersensitivity
  • A negative result does not entirely eliminate the risk of adverse reactions
  • Results should be interpreted in conjunction with clinical history and other diagnostic findings

Risks & Considerations

  • Minor bruising or discomfort at blood draw site
  • Rare risk of infection or fainting during blood collection
  • No significant risks from buccal swab collection

Interfering Factors

  • Hemolyzed or lipemic blood samples may affect DNA extraction
  • Recent blood transfusions could lead to false results
  • Improper sample collection or storage

Compare With Similar Tests

TestHLA Hypersensitivity to Carbamazepine & Phenytoin (B*15:02) TestHLA-A*31:01 Test
ComparisonHLA Hypersensitivity to Carbamazepine & Phenytoin (B*15:02) Test

Frequently Asked Questions

What is the HLA B*15:02 test?
It is a genetic test that detects the HLA-B*15:02 allele, which indicates increased risk for severe drug hypersensitivity reactions to carbamazepine and phenytoin.
Why is this test important?
It helps prevent life-threatening conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) by identifying at-risk individuals before medication use.
Who should get this test?
Patients prescribed carbamazepine or phenytoin, especially those with a history of drug reactions or from high-risk ethnic groups like Chinese, South East Asian, or Indian populations.
How is the test performed?
A small blood sample or buccal swab is collected and analyzed using PCR and sequencing techniques to detect the HLA-B*15:02 allele.
What is the cost of the test?
The test costs INR 8000, which includes sample collection, analysis, and genetic counseling.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for online bookings across India.
What does a positive result mean?
A positive result means the HLA-B*15:02 allele is present, indicating a higher risk of hypersensitivity reactions. Your doctor may recommend alternative medications.
What does a negative result mean?
A negative result means the allele is not detected, suggesting lower risk, but monitoring for symptoms is still advised.
How long does it take to get results?
Results are typically available within 10-12 days after sample collection.
Are there any risks associated with the test?
The test involves minimal risks, such as minor bruising from blood draw. It is non-invasive and safe.
Can this test be used for other drugs?
This specific test is for carbamazepine and phenytoin. Related tests exist for other drugs like lamotrigene.
Is the test covered by insurance?
Coverage varies by insurance provider. It is not typically covered under government schemes like PMJAY or CGHS; check with your insurer for details.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.